MedTrace Logo

The Treatment Effectiveness of Combined tDCs and Neurofeedback (NF) for Patients With Cognitive Deficits After Stroke

NCT03093142 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-03-06

No results posted yet for this study

Summary

This is a double blinded, randomized control trial with a pretest-posttest control and interventional groups design. Both the assessor and participants are blinded to all assessments and evaluations. All patients with subacute stroke undergo in-patient or out-patient rehabilitation are screened initially by a series of screening test. Suitable patients are assigned randomly to 3 groups respectively. Group 1 is the combined transcranial direct current stimulation (tDCS) and neurofeedback group. Group 2 is the neurofeedback group. Group 3 is the control group with sham neurofeedback training.

Conditions

Interventions

DEVICE

tDCS & neurofeedback

tDCs and neurofeedback

DEVICE

neurofeedback

Neurofeedback

DEVICE

sham neurofeedback

sham neurofeedback

Sponsors & Collaborators

  • Chinese University of Hong Kong

    collaborator OTHER

  • Kowloon Hospital, Hong Kong

    lead OTHER

Principal Investigators

  • Marko Chan, PhDCandidate · Community Rehabilitation Service Supoort Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2020-12-30
Completion
2020-12-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03093142 on ClinicalTrials.gov